Review of Applications of Cyclodextrins as Taste-Masking Excipients for Pharmaceutical Purposes.
cyclodextrins
electronic tongue
excipients
inclusion complexes
taste masking
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
07 Oct 2023
07 Oct 2023
Historique:
received:
08
09
2023
revised:
25
09
2023
accepted:
04
10
2023
medline:
23
10
2023
pubmed:
14
10
2023
entrez:
14
10
2023
Statut:
epublish
Résumé
It is widely recognized that many active pharmaceutical ingredients (APIs) have a disagreeable taste that affects patient acceptability, particularly in children. Consequently, developing dosage forms with a masked taste has attracted a lot of interest. The application of cyclodextrins as pharmaceutical excipients is highly appreciated and well established, including their roles as drug delivery systems, solubilizers and absorption promoters, agents that improve drug stability, or even APIs. The first work describing the application of the taste-masking properties of CDs as pharmaceutical excipients was published in 2001. Since then, numerous studies have shown that these cyclic oligosaccharides can be effectively used for such purposes. Therefore, the aim of this review is to provide insight into studies in this area. To achieve this aim, a systematic evaluation was conducted, which resulted in the selection of 67 works representing both successful and unsuccessful works describing the application of CDs as taste-masking excipients. Particular attention has been given to the methods of evaluation of the taste-masking properties and the factors affecting the outcomes, such as the choice of the proper cyclodextrin or guest-host molar ratio. The conclusions of this review reveal that the application of CDs is not straightforward; nevertheless, this solution can be an effective, safe, and inexpensive method of taste masking for pharmaceutical purposes.
Identifiants
pubmed: 37836807
pii: molecules28196964
doi: 10.3390/molecules28196964
pmc: PMC10574773
pii:
doi:
Substances chimiques
Pharmaceutical Preparations
0
Excipients
0
Cyclodextrins
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
AAPS PharmSciTech. 2008;9(3):1025-30
pubmed: 18770047
Drug Des Devel Ther. 2015 Sep 07;9:5135-46
pubmed: 26379426
Drug Dev Ind Pharm. 2020 Dec;46(12):2070-2080
pubmed: 33112681
Ther Deliv. 2023 Jul;14(7):443-458
pubmed: 37464784
AAPS PharmSciTech. 2023 Feb 14;24(2):67
pubmed: 36788171
Drug Dev Ind Pharm. 2021 Apr;47(4):645-653
pubmed: 33826435
Int J Pharm. 2021 Nov 20;609:121113
pubmed: 34543619
Asian J Pharm Sci. 2019 Mar;14(2):183-192
pubmed: 32104450
Drug Dev Ind Pharm. 2015 Jun;41(6):1006-16
pubmed: 24865111
Adv Carbohydr Chem. 1957;12:189-260
pubmed: 13617118
Int J Mol Sci. 2023 Feb 11;24(4):
pubmed: 36835054
Int J Pharm. 2011 Jul 15;413(1-2):63-72
pubmed: 21540089
Pharmaceutics. 2019 Jan 01;11(1):
pubmed: 30609647
AAPS PharmSciTech. 2008;9(2):349-56
pubmed: 18431674
AAPS PharmSciTech. 2008;9(2):544-50
pubmed: 18431648
Curr Drug Deliv. 2010 Jan;7(1):21-7
pubmed: 19863484
Pharmaceutics. 2022 Nov 22;14(12):
pubmed: 36559052
J Pharm Pharmacol. 2023 Feb 8;75(2):236-244
pubmed: 36548517
Chem Rev. 2014 Nov 12;114(21):10940-75
pubmed: 25247843
J Pharm Sci. 2010 Oct;99(10):4285-94
pubmed: 20737636
J Pediatr Pharmacol Ther. 2018 Sep-Oct;23(5):405-409
pubmed: 30429695
Int J Pharm. 2010 Sep 15;397(1-2):1-8
pubmed: 20600734
Asian J Pharm Sci. 2020 Jul;15(4):492-505
pubmed: 32952672
Pharmaceutics. 2020 Aug 07;12(8):
pubmed: 32784691
Int J Pharm Investig. 2012 Jul;2(3):162-8
pubmed: 23373008
Nat Rev Neurosci. 2017 Aug;18(8):485-497
pubmed: 28655883
Chem Pharm Bull (Tokyo). 2006 Aug;54(8):1155-61
pubmed: 16880661
Sensors (Basel). 2020 Jan 27;20(3):
pubmed: 32012652
RSC Adv. 2018 Jan 17;8(7):3564-3573
pubmed: 35542937
Int J Mol Sci. 2015 Mar 13;16(3):5945-74
pubmed: 25782158
Prev Nutr Food Sci. 2022 Dec 31;27(4):354-364
pubmed: 36721748
Pharmaceutics. 2021 Jul 20;13(7):
pubmed: 34371790
Pharmaceutics. 2022 Jul 11;14(7):
pubmed: 35890336
Chem Phys Lipids. 2021 Mar;235:105031
pubmed: 33352198
Chem Rev. 1998 Jul 30;98(5):1743-1754
pubmed: 11848947
Trends Biochem Sci. 2009 Jun;34(6):296-302
pubmed: 19443222
Pharm Res. 2014 Nov;31(11):2921-39
pubmed: 25205460
Pflugers Arch. 2021 Jan;473(1):3-13
pubmed: 32936320
AAPS PharmSciTech. 2013 Sep;14(3):1118-28
pubmed: 23835739
Int J Pharm. 2015 Jun 20;487(1-2):213-22
pubmed: 25899284
AAPS PharmSciTech. 2015 Apr;16(2):455-65
pubmed: 25361901
Anal Chim Acta. 2019 Oct 24;1077:14-29
pubmed: 31307702
PLoS One. 2022 Jun 3;17(6):e0269278
pubmed: 35657815
J Pharm Sci. 2011 Aug;100(8):3177-3185
pubmed: 21394723
Front Pharmacol. 2020 Nov 30;11:587664
pubmed: 33390961
Drug Dev Ind Pharm. 2015;41(12):2029-36
pubmed: 26006328
AAPS PharmSciTech. 2017 Aug;18(6):2055-2066
pubmed: 27995465
Adv Biomed Res. 2014 Mar 25;3:92
pubmed: 24800181
J Food Sci. 2021 Sep;86(9):4026-4036
pubmed: 34409609
Arch Dis Child. 2012 Mar;97(3):293-7
pubmed: 22088684
Pharmaceutics. 2022 Apr 03;14(4):
pubmed: 35456614
J Pharm Sci. 2011 May;100(5):1935-43
pubmed: 21374625
Int J Pharm. 2015 Aug 1;491(1-2):8-16
pubmed: 26051543
Drug Dev Ind Pharm. 2012 Sep;38(9):1061-7
pubmed: 22185653
Pharmaceutics. 2021 Jul 30;13(8):
pubmed: 34452141
Pharm Dev Technol. 2010 Jun;15(3):276-85
pubmed: 22716468
J Food Sci Technol. 2023 May;60(5):1521-1529
pubmed: 37033307
Pharmaceutics. 2022 Aug 22;14(8):
pubmed: 36015374
Pharmaceutics. 2021 Nov 13;13(11):
pubmed: 34834338